3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Classical hematology
1
Conditions
Breast Neoplasms
11
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Endometrial Neoplasms
4
Colorectal Neoplasms, Hereditary Nonpolyposis
4
Brain Neoplasms
3
Urogenital Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms, Unknown Primary
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8
1
Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Pyloric Stenosis, Hypertrophic
1
Primary Ovarian Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pancreatic Ductal Adenocarcinoma
1
Neurofibromatosis 1
1
Neoplastic Syndromes, Hereditary
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lipodystrophy, Familial Partial
1
Leukemia, Myeloid, Acute
1
Interventions
Cyclophosphamide
409
Methotrexate
246
Cytarabine
231
Vincristine
188
fludarabine phosphate
172
Dexamethasone
169
fludarabine
143
Etoposide
143
Peripheral Blood Stem Cell Transplantation
136
Filgrastim
132
Whole-Body Irradiation
116
Mycophenolic Acid
115
Busulfan
112
Doxorubicin
109
Tacrolimus
106
Mercaptopurine
105
Cyclosporine
95
Radiotherapy
93
Melphalan
93
Rituximab
90
pegaspargase
88
Prednisone
84
Asparaginase
84
Daunorubicin
82
Granulocyte Colony-Stimulating Factor
74
blinatumomab
72
Antilymphocyte Serum
71
Calcium Dobesilate
69
Clofarabine
58
Thiotepa
55
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Genetic Testing
×
Clear all
NCT04168788
2019-11-19
MVO
University Hospital, Angers
Phase NA
Unknown
150 enrolled